The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | Testing drugs in isolated cells from patients with CLL: advances and limitations
Cristina Scielzo, PhD, IRCCS, San Raffaele Scientific Institute, Milan, Italy, discusses how isolated cells from patients with chronic lymphocytic leukemia (CLL) can be used to test drugs. However, she mentions several limitations, including the fact that it is not easy to replicate the entire microenvironment and the cost and space required. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
